Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-005363
Filing Date
2021-11-09
Accepted
2021-11-09 16:50:29
Documents
40
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sunshine_i10q-093021.htm   iXBRL 10-Q 586512
2 CERTIFICATION sunshine_ex03101.htm EX-31.1 10812
3 CERTIFICATION sunshine_ex03102.htm EX-31.2 10800
4 CERTIFICATION sunshine_ex032.htm EX-32 4515
5 GRAPHIC figure1.jpg GRAPHIC 11410
6 GRAPHIC figure2.jpg GRAPHIC 12785
7 GRAPHIC figure3.jpg GRAPHIC 12371
8 GRAPHIC figure4.jpg GRAPHIC 7060
  Complete submission text file 0001683168-21-005363.txt   2807280

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE sbfm-20210930.xsd EX-101.SCH 19329
10 XBRL CALCULATION FILE sbfm-20210930_cal.xml EX-101.CAL 37667
11 XBRL DEFINITION FILE sbfm-20210930_def.xml EX-101.DEF 79767
12 XBRL LABEL FILE sbfm-20210930_lab.xml EX-101.LAB 168742
13 XBRL PRESENTATION FILE sbfm-20210930_pre.xml EX-101.PRE 136858
14 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10q-093021_htm.xml XML 241854
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 211392967
SIC: 8731 Services-Commercial Physical & Biological Research